Gyre Therapeutics
GYRE
£5.97
Share price
-15.26%
Change (1 day)
-52.38%
Change (1 year)
Categories
Operating Margin for Gyre Therapeutics (GYRE)
Operating Margin as of April 2025 (TTM): 15.34%
According to Gyre Therapeutics's latest financial reports and stock price the company's current Operating Margin is 15.34%. At the end of 2024 the company had an Operating Margin of 15.35%.
Operating Margin history for Gyre Therapeutics from 2022 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 15.35% | -9.39% |
| 2023 | 16.94% | 88.23% |
| 2022 | 9.00% | -72.89% |
| 2021 | 33.18% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.